Our extensive engagement with all segments of the healthcare spectrum – including primary and secondary care and pharmaceutical sites – and our federal and state legislative presence enables us to educate, influence and collaborate with policymakers on important pharmaceutical distribution and healthcare issues.
Championing healthier futures
Industry stewardship & policy priorities
We support regulatory and legislative policies that help ensure more people can access and afford needed treatments – including individuals negatively affected by the social determinants of health, such as race, education, ethnicity, social and economic status and those living in underserved urban and rural locations. Our key-issue advocacy focus includes safe, efficient and reliable delivery of medicines, promoting the evolution of pharmaceutical benefit design and supporting the emerging biosimilars market.
Advocating for community-based pharmacies
Our Independent Voice
Advocating for independent, community practices
Q&A: Predictions for healthcare costs, patient access, and reform in 2021
Let's Ditch 2020 and Plan for 2021: Election What-Ifs
Biosimilars: Patents, policy, and reimbursement
In the News
Media Statement on Federal Retail Pharmacy Program
With the start of the Federal Retail Pharmacy Program, AmerisourceBergen will formally begin its role as a “network administrator” and place orders with the U.S. Centers for Disease Control and Prevention (CDC) on behalf of an initial set of eligible and qualified Good Neighbor Pharmacy and Elevate Provider Network members in certain areas.
AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine
Advocating for Independent Community Pharmacies on Federal and State Levels
September 17, 2020
Connect with us